Notably, loss of PU.1 activity is closely associated with myeloid leukemia, and the PU.1 network is commonly disrupted in myeloid hematological malignancies, though PU.1 itself is rarely mutated (Will et al., 2015; Aivalioti et al., 2022). The gene discussed is SPI1; the disease is myeloid leukemia.